Two stocks in the biotech space had dramatic moves over the last two days. One in Trevena Inc (TRVN), which moved from about $0.60 to nearly $1.50 per share over the last two days. The stock was up due to news of a pathway to possible FDA approval for its flagship product. The other big mover is Oncocyte Corp (OCX), whose stock rose from the low $2 range to nearly $7 per share over the last couple of days. Here’s what’s been moving them.
A high-profile policy debate has re-entered the financial spotlight surrounding credit card interest rate caps. Last week, President Donald Trump called for a temporary national cap on credit card interest rates. He proposed a maximum annual rate of 10% over a one-year period, starting January 20, 2026. President Trump’s proposal would aim to combat the […]
Read Article
Make no mistake…day trading options can be very profitable, but it can also be very risky. If you don’t know what you’re doing—you will get burned. When I first started day trading options, I learned that lesson the hard way quite a few times, but those experiences made me a better trader and coach. I’ll […]
Read Article
What is Prop Trading? Prop trading has exploded in popularity over the last five years. It’s transformed from a niche practice into a mainstream gateway for retail traders. There’s a lot of highly skilled traders out there who are sitting on the sidelines right now for two main reasons: Prop trading addresses both issues. In […]
Read Article
There’s been a huge chip stock rally in the market that’s turning a lot of heads. Here are just a few examples: Chip stocks were among the big names that dominated at CES this year in Las Vegas. In addition to the growing demand for chips, AI, and data storage, it’s understandable why there’s so […]
Read Article
Traders started planning ahead for 2026 well in advance, with tech stocks being a major focus.It’s no secret that tech stocks have a huge influence on the market—in addition to the huge trading opportunities they can offer. Factors like high volume, volatility, and liquidity make tech stocks very attractive assets for traders to consider following. […]
Read Article
With a full day of New Year’s Eve trading ahead of us, a lot of traders are wondering if any surprises might await them on the last trading day of 2025. Today will close out what has been an eventful year in the market. Trading was affected by significant events—from Liberation Day and a lengthy […]
Read ArticleWe choose to let our members and students speak for themselves. We do not actively solicit testimonials, no compensation has been paid for any testimonial, and testimonials are not necessarily representative of the experience of all students. All monetary claims made in testimonials that you see depicted in our marketing material have been verified by Prosper Trading Academy and attested to by the members that have given them. Verified testimonials encompass “experience” reviews that highlight the personal experiences of working with our team and “performance” testimonials where we verify trading success of students who have enrolled in our programs.Given the broad reach of the internet, testimonials and reviews of our programs that we have not been able to verify can be found on various websites across the internet which are beyond our editorial control. While we do very much enjoy hearing positive things from our students and it is critical to our mission that everyone is satisfied with their journey with Prosper, we encourage you to take both verified and unverified testimonials for what they are.